Entrada Therapeutics is a clinical-stage biopharmaceutical company focused on developing a new class of medicines for hard-to-reach intracellular targets. The company is advancing a portfolio of genetic medicines for neuromuscular and inherited retinal diseases. Entrada has a catalyst-rich period approaching, with multiple clinical data readouts expected by the end of 2026 for its Duchenne muscular dystrophy (DMD) programs and an ongoing collaboration with Vertex Pharmaceuticals for myotonic dystrophy type 1 (DM1). Entrada is seeking motivated, resourceful, and enthusiastic individuals to join its high-energy, dedicated team.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Mid Level